ORASURE TECHNOLOGIES INC announced its consolidated financial results for full year and quarter ended December 31, 2022, held a webcast conference call with analysts and investors, and announced a business restructuring to combine its Molecular Solutions and Diagnostics business units resulting in the elimination of roles impacting approximately 11% of its current non-production workforce.